Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: potential role in therapy.
Enviado por María del Pilar Torres-González el
Título | Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: potential role in therapy. |
Publication Type | Journal Article |
Year of Publication | 2013 |
Autores | Shimizu, T, Torres, MP, Chakraborty, S, Souchek, JJ, Rachagani, S, Kaur, S, Macha, M, Ganti, AK, Hauke, RJ, Batra, SK |
Journal | Cancer Lett |
Volume | 336 |
Issue | 2 |
Pagination | 270-80 |
Date Published | 2013 Aug 19 |
ISSN | 1872-7980 |
Abstract | There is an urgent need to develop alternative therapies against lethal pancreatic cancer (PC). Ocimum sanctum ("Holy Basil") has been used for thousands of years in traditional Indian medicine, but its anti-tumorigenic effect remains largely unexplored. Here, we show that extracts of O. sanctum leaves inhibit the proliferation, migration, invasion, and induce apoptosis of PC cells in vitro. The expression of genes that promote the proliferation, migration and invasion of PC cells including activated ERK-1/2, FAK, and p65 (subunit of NF-κB), was downregulated in PC cells after O. sanctum treatment. Intraperitoneal injections of the aqueous extract significantly inhibited the growth of orthotopically transplanted PC cells in vivo (p<0.05). Genes that inhibit metastasis (E-cadherin) and induce apoptosis (BAD) were significantly upregulated in tumors isolated from mice treated with O. sanctum extracts, while genes that promote survival (Bcl-2 and Bcl-xL) and chemo/radiation resistance (AURKA, Chk1 and Survivin) were downregulated. Overall, our study suggests that leaves of O. sanctum could be a potential source of novel anticancer compounds in the future. |
DOI | 10.1016/j.canlet.2013.03.017 |
Alternate Journal | Cancer Lett. |
PubMed ID | 23523869 |
PubMed Central ID | PMC3700662 |
Grant List | P50 CA127297 / CA / NCI NIH HHS / United States P50 CA127297 / CA / NCI NIH HHS / United States T32CA009476 / CA / NCI NIH HHS / United States U01 CA111294 / CA / NCI NIH HHS / United States U54 CA160163 / CA / NCI NIH HHS / United States |